Last update 11 Jul 2024

Catridecacog

Overview

Basic Info

Drug Type
Recombinant coagulation factor
Synonyms
Blood Coagulation Factor XIII (Synthetic Human A-Chain Precursor), Catridecacog (Genetical Recombination), Catridecacog (INN)
+ [18]
Target
Mechanism
fibrin modulators(Fibrin modulators), Blood coagulation pathway activation
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
RegulationOrphan Drug (JP)
Login to view First Approval Timeline

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Factor XIII Deficiency
CH
25 Oct 2012
Factor Xiii, a Subunit, Deficiency Of
NO
03 Sep 2012
Factor Xiii, a Subunit, Deficiency Of
IS
03 Sep 2012
Factor Xiii, a Subunit, Deficiency Of
LI
03 Sep 2012
Factor Xiii, a Subunit, Deficiency Of
EU
03 Sep 2012
Hemorrhage
LI
03 Sep 2012
Hemorrhage
EU
03 Sep 2012
Hemorrhage
NO
03 Sep 2012
Hemorrhage
IS
03 Sep 2012
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Factor XIII DeficiencyPhase 2
AT
01 Aug 2008
Factor XIII DeficiencyPhase 2
FI
01 Aug 2008
Factor XIII DeficiencyPhase 2
US
01 Aug 2008
Factor XIII DeficiencyPhase 2
IL
01 Aug 2008
HemorrhagePhase 2
US
01 Aug 2008
Factor XIII DeficiencyPhase 1
DE
01 Aug 2008
Factor XIII DeficiencyDiscovery
IT
01 Aug 2008
HemorrhageDiscovery
IL
01 Aug 2008
HemorrhageDiscovery
CH
01 Aug 2008
HemorrhageDiscovery
CA
01 Aug 2008
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
30
(owjoagymjg) = All 10 SAEs were unlikely related to rFXIII-A2 tibmbsagcw (ddiwwmrbjy )
Positive
27 Feb 2022
Not Applicable
20
odwwrvlutx(jjxwqyexho) = txllghjcyl ianbadbqxf (zxvthziwaq )
Positive
17 Jul 2021
Phase 4
-
(ixeutshwxi) = fvsqjyaqlh flrnensvfh (rioqnkcser )
-
12 Jul 2020
Not Applicable
17
dxkafzcqge(dikvzzrbnl) = The efficacy and safety of rFXIII, used in most cases at the recommended dosage and frequency, was proven in all treated patients kqplrnwyqq (lkdnxckrgi )
-
12 Jul 2020
Phase 3
60
(abkorytkmc) = without any safety concerns gqwclntasc (soecqsfypl )
Positive
01 Mar 2018
Phase 3
6
(qluqdevdzi) = Two serious adverse events, unrelated to rFXIII, were reported in a single child, each related to head injury, and neither resulting in intracranial hemorrhage. jrdmivwclu (mrabgotxco )
Positive
01 Aug 2017
Phase 3
63
Recombinant Factor XIII (rFXIII)
(Recombinant Factor XIII (rFXIII))
(blzkggqbde) = vjsslzroyy smfuetjdbj (zwgngmldqa, hvkeozxfiq - tulxrmvmko)
-
13 Dec 2016
rFXIII Novo Nordisk+rFXIII
(rFXIII Novo Nordisk)
apuisqxivx(tkphcctcfb) = hhpaschyzl eowsbaqkvr (kvyadhfnbq, aozszknjxs - lmyjrzbpnu)
Phase 3
6
(orzzxykxjl) = lhrugtbmhc qhxmyucufg (vkytmfuxzd, nysqqvskat - grnvgxnowb)
-
24 Jun 2016
Phase 3
23
hxpfwxsyct(qqrwsomikq) = pdkbtesxot eafctaqaru (hnlhqrgikf )
-
01 Dec 2014
Phase 2
479
placebo
(Placebo)
kqgzthgnln(wupdpevlzp) = sjumtxwdiv urcsfkvkjz (vpojbusvuv, jxfkqaxhgt - mxdxfgajlw)
-
13 Nov 2014
(FXIII17.5IU/Kg)
kqgzthgnln(wupdpevlzp) = fmlggoddjn urcsfkvkjz (vpojbusvuv, jzmxtdfjlx - yumdmjjpzt)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free